´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö : 2023-05-27
±³À°ÀÏÀÚ : 2023-05-27
±³À°Àå¼Ò : ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ : ´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀμº¼îÅ©¿¬±¸È¸
´ã´çÀÚ : ±èÀºÁø
¿¬¶ôó : 02-3410-6475
À̸ÞÀÏ : kscwg2021@gmail.com
±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:05~09:20 Consumptive coagulopathy and anti-coagulation therapy Àå¿ìÁø(À̴뼿ﺴ¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:20~09:35 Central ECMO: when? whom? È«Á¤¾Ö(ÇѸ²´ë¼º½Éº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:35~09:50 Infection surveillance and antibiotics selection À§Áø(°¡Ãµ´ë ±æº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:50~10:05 Transfusion strategy: is it different from other critically-ill conditions? ±èÈñÁß(°í´ë¾È¾Ïº´¿ø)
Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:05~10:30 Åä·Ð ( )
ÈÞ½Ä 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:40 ÈÞ½Ä ( )
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:40~10:55 AMI: revascularization strategy including CABG and MCS timing ±è¹Îö(Àü³²´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:55~11:10 Heart failure related cardiogenic shock: inotropes, vasopressor, MCS transition À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:10~11:25 Fulminant Myocarditis: optimal timing of biopsy, MCS, and cardiac replacement therapy Á¶Çü¿ø(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:25~11:40 Mixed or undifferentiated shock ±è¾Æ¶÷(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:40~12:00 Åä·Ð ( )
½Ä»ç 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:00~13:00 ½Ä»ç ( )
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:00~13:15 RESCUE SHOCK trial and CLEAN ECMO trial ¾çÁ¤ÈÆ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:15~13:30 Timing of LV unloading and limb ischemia proctection in VA-ECMO ±è¹Î¼®(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:30~13:45 International ongoing trials on CS °ÁöÈÆ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:45~14:00 Perspectives in Cardiogenic Shock in Korea ±ÇÇöö(»ï¼º¼¿ïº´¿ø)
Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:00~14:20 Åä·Ð ( )
ÈÞ½Ä 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:30 ÈÞ½Ä ( )
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:50 ºòµ¥ÀÌÅ͸¦ ÅëÇÑ Çѱ¹Àο¡¼ ½ÉÀμº¼îÅ©ÀÇ Ä¡·á ÇöȲ ÃÖ±âÈ«(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:50~15:10 Àü¹®°¡ ¼³¹®À» ÅëÇÑ ÇöÀçÀÇ ¹®Á¦Á¡°ú ÇØ°á ¹æÇâÀÇ ¿ì¼±¼øÀ§ °´Üºñ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:10~15:30 ½ÉÀå³»¿Ü°ú ÁßȯÀڽǿ¡¼ Suregen ÁßȯÀÚ Àü´ãÀÇÀÇ ¿ªÇÒ°ú ÀÚ°ÝÀº ¹«¾ùÀΰ¡? ÀåÇü¿ì(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:30~15:50 ÁßȯÀÚ½Ç »ýÁ¸ÀÚµéÀÇ ÀÏ»ó»ýÈ°·ÎÀÇ º¹±Í´Â ¾î¶»°Ô ÀÌ·ç¾îÁ®¾ßÇϴ°¡? À̸¸Á¾(ÀÎÇϴ뺴¿ø)
Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:10 Åä·Ð ( )